Destiny Wealth Partners’s Quest Diagnostics DGX Stock Holding History

Destiny Wealth Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$932K	Hold	4,000	–	–	0.13%	73
2026 Q1	$784K	Hold	4,000	–	–	0.09%	113
2025 Q4	$730K	Hold	4,000	–	–	0.08%	107
2025 Q3	$762K	Hold	4,000	–	–	0.09%	101
2025 Q2	$719K	Hold	4,000	–	–	0.1%	100
2025 Q1	$677K	Hold	4,000	–	–	0.11%	95
2024 Q4	$603K	Hold	4,000	–	–	0.1%	102
2024 Q3	$621K	Hold	4,000	–	–	0.11%	94
2024 Q2	$548K	Hold	4,000	–	–	0.1%	94
2024 Q1	$532K	Hold	4,000	–	–	0.1%	93
2023 Q4	$562K	Hold	4,000	–	–	0.11%	89
2023 Q3	$487K	Hold	4,000	–	–	0.1%	99
2023 Q2	$577K	Sell	4,000 -10	-0.2%	-$1.38K	0.11%	92
2023 Q1	$567K	Sell	4,010 -555	-12%	-$79.4K	0.12%	90
2022 Q4	$714K	Sell	4,565 -116	-2%	-$16.7K	0.15%	85
2022 Q3	$574K	Buy	4,681 +4,000	+587%	+$527K	0.13%	89
2022 Q2	$91K	Hold	681	–	–	0.02%	241
2022 Q1	$93K	Hold	681	–	–	0.02%	257
2021 Q4	$118K	Hold	681	–	–	0.02%	219
2021 Q3	$99K	Buy	+681	New	+$99.6K	0.02%	214
2021 Q2	–	Sell	-681	Closed	-$87K	–	258
2021 Q1	$87K	Hold	681	–	–	0.02%	212
2020 Q4	$81K	Buy	+681	New	+$83K	0.02%	245

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Destiny Wealth Partners's DGX Position: Q2 2026 in Review

Destiny Wealth Partners held its Quest Diagnostics (DGX) position steady in Q2 2026 at 4,000 shares worth $932K. The position accounts for 0.13% of the portfolio, ranked #73.

Destiny Wealth Partners first reported a position in DGX in Q4 2020 and has held it in 22 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Destiny Wealth Partners held 4,000 shares of Quest Diagnostics worth $932K as of Q2 2026.
Destiny Wealth Partners left its Quest Diagnostics share count unchanged in Q2 2026.
Quest Diagnostics made up 0.13% of Destiny Wealth Partners's portfolio in Q2 2026, its #73 holding.
Destiny Wealth Partners first reported a position in Quest Diagnostics in Q4 2020 and has held it in 22 quarters since.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.